Chemed Corp (CHE) reported $2.66B of revenue for the twelve months ended Sep 30, 2026. That is up 5.2% from the year before. Revenue for fiscal 2025 was $2.53B.

Yes. Chemed Corp earned $282.40M in net income for the twelve months ended Sep 30, 2026, a net margin of 10.6%.

How much cash and debt does CHE have?

Chemed Corp reported $48.43M in cash and cash equivalents and $236.00M of debt on its most recent balance sheet in SEC filings.

How fast is CHE revenue growing?

Chemed Corp's revenue changed +4.1% in fiscal 2025, to $2.53B. Its compound annual growth rate was +4.0% over 5 years and +5.1% over 10 years.

What is CHE gross margin?

Chemed Corp's gross profit was $892.52M on $2.66B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 33.5%.

What is CHE free cash flow?

Chemed Corp generated $295.45M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $363.15M less capital expenditures.

What is CHE earnings per share?

Diluted earnings per share were $20.87 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did CHE last report financial results?

The latest statements here come from Chemed Corp's 10-Q filed on Oct 29, 2026, covering the period ended Sep 30, 2026.

Where does this CHE financial data come from?

Quantisnow builds these statements from the structured XBRL data Chemed Corp files with the SEC. It is provided for information only and is not investment advice.

Financials · CHE

Chemed Corp (CHE) financials

For the twelve months ended Sep 30, 2026, Chemed Corp reported $2.66B of revenue and $282.40M of net income.

Revenue, TTM: $2.66B
Revenue growth, YoY: +5.2%
Net income, TTM: $282.40M
Net income growth, YoY: +1.3%
Net margin: 10.6%
Free cash flow, TTM: $295.45M
EPS, diluted, TTM: $20.87
EPS growth, YoY: +10.5%
Cash: $48.43M
Total debt: $236.00M
P/E: 24.34
P/S: 2.58
Market cap: $6.87B

Annual revenue$2.53B

FY2016FY2025

Annual net income$265.24M

FY2016FY2025

Annual free cash flow$325.48M

FY2016FY2025

CHE revenue and earnings growth

CHE revenueQ3 2026$690.94M

Quarter YoY: +10.6%
QoQ: +2.6%
FY YoY: +4.1%
5Y CAGR: +4.0%
10Y CAGR: +5.1%

CHE revenue was $690.94M in fiscal Q3 2026 (ended Sep 30, 2026), up 10.6% from a year earlier and up 2.6% from the prior quarter. For the full fiscal 2025 it was $2.53B, up 4.1% from fiscal 2024. Compound annual growth was +4.0% over 5 years and +5.1% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

CHE net incomeQ3 2026$71.65M

Quarter YoY: +11.5%
QoQ: +5.8%
FY YoY: -12.2%
5Y CAGR: -3.7%
10Y CAGR: +9.2%

CHE net income was $71.65M in fiscal Q3 2026 (ended Sep 30, 2026), up 11.5% from a year earlier and up 5.8% from the prior quarter. For the full fiscal 2025 it was $265.24M, down 12.2% from fiscal 2024. Compound annual growth was -3.7% over 5 years and +9.2% over 10 years. It rose in 5 of the last 10 fiscal years.

CHE EPSQ3 2026$5.45

Quarter YoY: +22.2%
QoQ: +6.2%
FY YoY: -7.8%
5Y CAGR: -1.2%
10Y CAGR: +11.2%

CHE diluted EPS was $5.45 in fiscal Q3 2026 (ended Sep 30, 2026), up 22.2% from a year earlier and up 6.2% from the prior quarter. For the full fiscal 2025 it was $18.34, down 7.8% from fiscal 2024. Compound annual growth was -1.2% over 5 years and +11.2% over 10 years.

CHE free cash flowQ3 2026$37.87M

Quarter YoY: -42.5%
QoQ: -45.3%
FY YoY: -11.5%
5Y CAGR: -5.4%
10Y CAGR: +9.8%

CHE free cash flow was $37.87M in fiscal Q3 2026 (ended Sep 30, 2026), down 42.5% from a year earlier and down 45.3% from the prior quarter. For the full fiscal 2025 it was $325.48M, down 11.5% from fiscal 2024. Compound annual growth was -5.4% over 5 years and +9.8% over 10 years. It rose in 7 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$2.53B	$2.43B	$2.26B	$2.13B	$2.14B	$2.08B	$1.94B	$1.78B	$1.67B	$1.58B
Cost of revenue	$1.71B	$1.58B	$1.47B	$1.37B	$1.37B	$1.38B	$1.32B	$1.23B	$1.15B	$1.12B
Gross profit	$823.18M	$854.35M	$798.82M	$765.09M	$769.80M	$701.39M	$617.43M	$555.00M	$516.19M	$461.45M
Selling, general and admin	$417.19M	$424.36M	$395.12M	$358.73M	$366.73M	$330.22M	$305.71M	$271.21M	$276.65M	$243.57M
Operating income	$338.25M	$366.49M	$340.57M	$343.50M	$343.04M	$389.68M	$257.38M	$243.63M	$113.03M	$178.75M
Interest expense	$1.75M	$1.78M	$3.11M	$4.58M	$1.87M	$2.35M	$4.54M	$4.99M	$4.27M	$3.71M
Pre-tax income	$355.78M	$399.46M	$350.37M	$329.68M	$350.31M	$395.99M	$261.61M	$239.60M	$116.92M	$177.05M
Income tax	$90.54M	$97.47M	$77.86M	$80.06M	$81.76M	$76.52M	$41.69M	$34.06M	$18.74M	$68.31M
Net income	$265.24M	$302.00M	$272.51M	$249.62M	$268.55M	$319.47M	$219.92M	$205.54M	$98.18M	$108.74M
EPS, basic	$18.42	$20.10	$18.11	$16.72	$17.14	$20.02	$13.77	$12.80	$6.11	$6.64
EPS, diluted	$18.34	$19.89	$17.93	$16.53	$16.85	$19.48	$13.31	$12.23	$5.86	$6.48
Diluted shares	14.5M	15.2M	15.2M	15.1M	15.9M	16.4M	16.5M	16.8M	16.7M	16.8M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$74.52M	$178.35M	$263.96M	$74.13M	$32.90M	$162.68M	$6.16M	$4.83M	$11.12M	$15.31M
Receivables	$182.57M	$171.16M	$181.51M	$139.41M	$137.22M	$126.85M	$143.83M	$119.50M	$113.65M	$132.02M
Inventory	$7.54M	$8.19M	$12.00M	$10.27M	$10.11M	$7.09M	$7.46M	$5.71M	$5.33M	$5.75M
Current assets	$302.62M	$394.75M	$500.84M	$272.61M	$230.29M	$329.40M	$190.67M	$159.84M	$176.05M	$169.90M
Goodwill	$667.00M	$666.74M	$585.02M	$581.29M	$578.59M	$578.59M	$577.37M	$510.57M	$476.89M	$472.37M
Total assets	$1.54B	$1.67B	$1.67B	$1.44B	$1.34B	$1.43B	$1.27B	$975.53M	$920.03M	$880.06M
Current liabilities	$287.13M	$285.69M	$312.05M	$297.20M	$302.40M	$299.11M	$262.22M	$191.67M	$193.52M	$171.83M
Short-term debt	-	-	-	$5.00M	-	-	-	-	$10.00M	$8.75M
Long-term debt	-	-	-	$92.50M	$185.00M	-	$90.00M	$89.20M	$91.20M	$100.00M
Total debt	-	-	-	$97.50M	$185.00M	-	$90.00M	$89.20M	$101.20M	$108.75M
Total liabilities	$558.78M	$549.58M	$560.22M	$643.30M	$719.45M	$533.71M	$541.71M	$384.19M	$379.67M	$355.96M
Shareholders' equity	$979.40M	$1.12B	$1.11B	$798.72M	$623.27M	$901.20M	$726.61M	$591.33M	$540.35M	$524.10M

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$388.27M	$417.50M	$330.30M	$309.89M	$308.60M	$489.29M	$301.25M	$287.14M	$162.50M	$135.39M
Capital expenditures	$62.80M	$49.53M	$56.85M	$57.33M	$58.67M	$58.83M	$53.02M	$52.87M	$64.30M	$39.77M
Free cash flow	$325.48M	$367.97M	$273.44M	$252.56M	$249.92M	$430.46M	$248.23M	$234.27M	$98.19M	$95.62M
Investing cash flow	-$59.34M	-$143.91M	-$60.64M	-$59.40M	-$57.76M	-$61.56M	-$190.76M	-$105.22M	-$67.61M	-$39.86M
Financing cash flow	-$432.77M	-$359.19M	-$79.83M	-$209.25M	-$380.62M	-$271.21M	-$109.16M	-$188.20M	-$99.08M	-$94.95M
Dividends paid	$31.70M	$27.09M	$23.50M	$22.02M	$22.02M	$21.08M	$19.79M	$18.66M	$17.37M	$16.44M
Share repurchases	$431.50M	$361.39M	$67.70M	$114.52M	$576.04M	$175.59M	$92.63M	$158.88M	$94.64M	$102.31M
Depreciation and amortization	$64.84M	$63.05M	$60.87M	$59.17M	$59.05M	$56.58M	$45.20M	$38.86M	$35.63M	$34.64M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	4.1%	7.4%	6.1%	-0.2%	2.9%	7.3%	8.7%	7.0%	5.7%	2.2%
Net income growth, YoY	-12.2%	10.8%	9.2%	-7.0%	-15.9%	45.3%	7.0%	109.4%	-9.7%	-1.4%
EPS growth, YoY	-7.8%	10.9%	8.5%	-1.9%	-13.5%	46.4%	8.8%	108.7%	-9.6%	2.4%
Gross margin	32.5%	35.1%	35.3%	35.8%	36.0%	33.7%	31.8%	31.1%	31.0%	29.3%
Operating margin	13.4%	15.1%	15.0%	16.1%	16.0%	18.7%	13.3%	13.7%	6.8%	11.3%
Net margin	10.5%	12.4%	12.0%	11.7%	12.6%	15.4%	11.3%	11.5%	5.9%	6.9%
Free cash flow margin	12.9%	15.1%	12.1%	11.8%	11.7%	20.7%	12.8%	13.1%	5.9%	6.1%
Return on equity	27.1%	27.0%	24.6%	31.3%	43.1%	35.4%	30.3%	34.8%	18.2%	20.7%
Return on assets	17.2%	18.1%	16.3%	17.3%	20.0%	22.3%	17.3%	21.1%	10.7%	12.4%
Current ratio	1.05	1.38	1.61	0.92	0.76	1.10	0.73	0.83	0.91	0.99
Debt to equity	-	-	-	0.12	0.30	-	0.12	0.15	0.19	0.21

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue	$690.94M	$673.25M	$657.51M	$639.34M	$624.90M	$618.80M	$646.94M	$639.99M	$606.18M	$595.88M	$589.23M	$585.91M
Cost of revenue	$457.98M	$451.78M	$441.75M	$417.02M	$425.14M	$434.11M	$430.53M	$405.88M	$396.19M	$389.75M	$385.13M	$358.35M
Gross profit	$232.96M	$221.47M	$215.76M	$222.32M	$199.76M	$184.69M	$216.41M	$234.12M	$209.99M	$206.13M	$204.11M	$227.57M
Selling, general and admin	$111.47M	$115.20M	$114.32M	$105.50M	$105.78M	$100.32M	$105.59M	$104.25M	$101.98M	$102.25M	$115.87M	$100.44M
Operating income	$96.42M	$89.20M	$84.58M	$100.65M	$74.75M	$68.08M	$94.76M	$113.88M	$92.16M	$88.13M	$72.33M	$111.39M
Interest expense	$2.10M	$1.79M	$512.0K	$521.0K	$457.0K	$443.0K	$329.0K	$499.0K	$427.0K	$429.0K	$425.0K	$342.0K
Pre-tax income	$96.71M	$91.33M	$88.84M	$105.44M	$83.54M	$71.11M	$95.67M	$120.12M	$101.03M	$93.83M	$84.48M	$115.59M
Income tax	$25.06M	$23.63M	$22.54M	$28.69M	$19.31M	$18.62M	$23.92M	$29.80M	$25.25M	$22.94M	$19.47M	$25.54M
Net income	$71.65M	$67.70M	$66.30M	$76.75M	$64.24M	$52.49M	$71.76M	$90.32M	$75.78M	$70.89M	$65.02M	$90.05M
EPS, basic	$5.49	$5.14	$4.85	$5.45	$4.46	$3.60	$4.91	$6.06	$5.04	$4.70	$4.30	$5.98
EPS, diluted	$5.45	$5.13	$4.84	$5.45	$4.46	$3.57	$4.86	$6.00	$5.00	$4.65	$4.24	$5.91
Diluted shares	13.1M	13.2M	13.7M	-	14.4M	14.7M	14.8M	-	15.2M	15.3M	15.3M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Cash and equivalents	$48.43M	$40.22M	$16.86M	$74.52M	$129.75M	$249.90M	$173.88M	$178.35M	$238.45M	$222.90M	$313.35M	$263.96M
Receivables	$254.86M	$188.63M	$215.48M	$182.57M	$215.57M	$184.88M	$285.87M	$171.16M	$196.48M	$184.96M	$177.33M	$181.51M
Inventory	$7.75M	$7.63M	$7.21M	$7.54M	$8.24M	$9.15M	$7.79M	$8.19M	$9.90M	$10.73M	$10.71M	$12.00M
Current assets	$365.73M	$291.24M	$274.06M	$302.62M	$395.24M	$491.38M	$502.38M	$394.75M	$490.44M	$464.61M	$539.62M	$500.84M
Goodwill	$754.76M	$667.00M	$667.00M	$667.00M	$666.99M	$667.00M	$666.94M	$666.74M	$666.86M	$662.12M	$591.52M	$585.02M
Total assets	$1.72B	$1.58B	$1.54B	$1.54B	$1.62B	$1.72B	$1.73B	$1.67B	$1.77B	$1.73B	$1.73B	$1.67B
Current liabilities	$330.93M	$319.85M	$321.42M	$287.13M	$292.04M	$263.89M	$290.56M	$285.69M	$264.78M	$261.75M	$281.97M	$312.05M
Long-term debt	$236.00M	$140.00M	$91.20M	-	-	-	-	-	-	-	-	-
Total debt	$236.00M	$140.00M	$91.20M	-	-	-	-	-	-	-	-	-
Total liabilities	$857.02M	$749.08M	$687.82M	$558.78M	$546.94M	$519.36M	$544.75M	$549.58M	$533.68M	$527.69M	$544.14M	$560.22M
Shareholders' equity	$861.42M	$830.51M	$847.99M	$979.40M	$1.08B	$1.20B	$1.18B	$1.12B	$1.24B	$1.21B	$1.18B	$1.11B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Operating cash flow	$56.59M	$84.81M	$88.22M	$133.53M	$83.39M	$138.61M	$32.74M	$164.91M	$90.52M	$77.52M	$84.55M	$108.56M
Capital expenditures	$18.72M	$15.52M	$17.12M	$16.35M	$17.50M	$15.81M	$13.28M	$12.76M	$18.65M	$96.43M	$12.16M	$11.78M
Free cash flow	$37.87M	$69.29M	$71.10M	$117.19M	$65.89M	$122.80M	$19.46M	$152.15M	$71.87M	-$18.91M	$72.39M	$96.78M
Investing cash flow	-$81.39M	-$28.24M	-$37.79M	-$15.95M	-$14.23M	-$15.48M	-$13.67M	-$12.52M	-$18.52M	-$93.49M	-$19.39M	-$11.67M
Financing cash flow	$33.01M	-$33.21M	-$108.09M	-$172.82M	-$189.31M	-$47.10M	-$23.54M	-$212.49M	-$56.45M	-$74.47M	-$15.77M	-$6.08M
Dividends paid	$9.19M	$7.88M	$8.17M	$8.50M	$8.65M	$7.22M	$7.33M	$7.50M	$7.49M	$6.06M	$6.05M	$6.06M
Share repurchases	$62.52M	$97.48M	$190.04M	$174.56M	$180.78M	$42.95M	$33.22M	$209.34M	$57.82M	$55.77M	$38.46M	$39.93M
Depreciation and amortization	$17.40M	$16.99M	$16.87M	$16.33M	$16.23M	$16.26M	$16.02M	$15.83M	$15.70M	$15.71M	$15.81M	$15.54M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue growth, YoY	10.6%	8.8%	1.6%	-0.1%	3.1%	3.8%	9.8%	9.2%	7.4%	7.6%	5.2%	7.2%
Net income growth, YoY	11.5%	29.0%	-7.6%	-15.0%	-15.2%	-25.9%	10.4%	0.3%	1.1%	32.8%	20.1%	45.0%
EPS growth, YoY	22.2%	43.7%	-0.4%	-9.2%	-10.8%	-23.2%	14.6%	1.5%	1.4%	32.5%	18.4%	43.1%
Gross margin	33.7%	32.9%	32.8%	34.8%	32.0%	29.8%	33.5%	36.6%	34.6%	34.6%	34.6%	38.8%
Operating margin	14.0%	13.2%	12.9%	15.7%	12.0%	11.0%	14.6%	17.8%	15.2%	14.8%	12.3%	19.0%
Net margin	10.4%	10.1%	10.1%	12.0%	10.3%	8.5%	11.1%	14.1%	12.5%	11.9%	11.0%	15.4%
Free cash flow margin	5.5%	10.3%	10.8%	18.3%	10.5%	19.8%	3.0%	23.8%	11.9%	-3.2%	12.3%	16.5%
Current ratio	1.11	0.91	0.85	1.05	1.35	1.86	1.73	1.38	1.85	1.78	1.91	1.61
Debt to equity	0.27	0.17	0.11	-	-	-	-	-	-	-	-	-

Source: XBRL data Chemed Corp files with the SEC, latest filing dated Oct 29, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

CHE peers

Company	Revenue	Growth	Net income	Net margin	Market cap
CHE	$2.66B	+5.2%	$282.40M	10.6%	$6.87B
BTSGBrightSpring Health Services Inc.	$15.25B	+26.0%	$410.27M	2.7%	$13.36B
HIMSHims & Hers Health Inc.	$2.58B	+28.0%	-$142.03M	-5.5%	$6.06B
LFSTLifeStance Health Group Inc.	$1.68B	+22.6%	$71.91M	4.3%	$5.26B
OPCHOption Care Health Inc.	$5.75B	+4.0%	$215.19M	3.7%	$4.74B
PRVAPrivia Health Group Inc.	$2.43B	+19.2%	$36.08M	1.5%	$3.12B
AVAHAveanna Healthcare Holdings Inc.	$2.60B	+19.5%	$274.76M	10.6%	$2.89B
ADUSAddus HomeCare Corporation	$1.50B	+11.5%	$111.05M	7.4%	$2.32B
WGSGeneDx Holdings Corp.	$454.43M	+25.4%	-$106.36M	-23.4%	$1.86B

CHE FAQ

9 questions

What is CHE revenue?
Chemed Corp (CHE) reported $2.66B of revenue for the twelve months ended Sep 30, 2026. That is up 5.2% from the year before. Revenue for fiscal 2025 was $2.53B.
Is CHE profitable?
Yes. Chemed Corp earned $282.40M in net income for the twelve months ended Sep 30, 2026, a net margin of 10.6%.
How much cash and debt does CHE have?
Chemed Corp reported $48.43M in cash and cash equivalents and $236.00M of debt on its most recent balance sheet in SEC filings.
How fast is CHE revenue growing?
Chemed Corp's revenue changed +4.1% in fiscal 2025, to $2.53B. Its compound annual growth rate was +4.0% over 5 years and +5.1% over 10 years.
What is CHE gross margin?
Chemed Corp's gross profit was $892.52M on $2.66B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 33.5%.
What is CHE free cash flow?
Chemed Corp generated $295.45M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $363.15M less capital expenditures.
What is CHE earnings per share?
Diluted earnings per share were $20.87 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did CHE last report financial results?
The latest statements here come from Chemed Corp's 10-Q filed on Oct 29, 2026, covering the period ended Sep 30, 2026.
Where does this CHE financial data come from?
Quantisnow builds these statements from the structured XBRL data Chemed Corp files with the SEC. It is provided for information only and is not investment advice.